157 related articles for article (PubMed ID: 17074642)
1. A family with Andersen-Tawil syndrome and dilated cardiomyopathy.
Schoonderwoerd BA; Wiesfeld AC; Wilde AA; van den Heuvel F; Van Tintelen JP; van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Heart Rhythm; 2006 Nov; 3(11):1346-50. PubMed ID: 17074642
[No Abstract] [Full Text] [Related]
2. Andersen-Tawil syndrome: an ever-expanding phenotype?
Tristani-Firouzi M
Heart Rhythm; 2006 Nov; 3(11):1351-2. PubMed ID: 17074643
[No Abstract] [Full Text] [Related]
3. Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation.
Nagase S; Kusano KF; Yoshida M; Ohe T
Heart Rhythm; 2007 Apr; 4(4):512-5. PubMed ID: 17399643
[TBL] [Abstract][Full Text] [Related]
4. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
5. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
[No Abstract] [Full Text] [Related]
6. Andersen-Tawil Syndrome with Early Onset Myopathy: 2 Cases.
Oz Tuncer G; Teber S; Kutluk MG; Albayrak P; Deda G
J Neuromuscul Dis; 2017; 4(1):93-95. PubMed ID: 28106564
[No Abstract] [Full Text] [Related]
7. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
8. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
[TBL] [Abstract][Full Text] [Related]
9. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
10. Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
Rezazadeh S; Guo J; Duff HJ; Ferrier RA; Gerull B
Can J Cardiol; 2016 Dec; 32(12):1576.e15-1576.e18. PubMed ID: 27789106
[TBL] [Abstract][Full Text] [Related]
11. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
[TBL] [Abstract][Full Text] [Related]
12. Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
Bigelow AM; Khalifa MM; Clark JM
Heart Rhythm; 2015 Jul; 12(7):1654-7. PubMed ID: 25814423
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
14. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
[No Abstract] [Full Text] [Related]
15. A study supporting possible expression of inward-rectifying potassium channel 2.1 channels in peripheral nerve in a patient with Andersen-Tawil syndrome.
Shibuya K; Tsuneyama A; Beppu M; Misawa S; Sekiguchi Y; Amino H; Suzuki YI; Suichi T; Nakamura K; Kuwabara S
Muscle Nerve; 2019 Apr; 59(4):E28-E30. PubMed ID: 30681175
[No Abstract] [Full Text] [Related]
16. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).
Tsuboi M; Antzelevitch C
Heart Rhythm; 2006 Mar; 3(3):328-35. PubMed ID: 16500306
[TBL] [Abstract][Full Text] [Related]
17. Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome.
Kim JB; Chung KW
Pediatr Neurol; 2009 Dec; 41(6):464-6. PubMed ID: 19931173
[TBL] [Abstract][Full Text] [Related]
18. Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation.
Díaz-Manera J; Querol L; Clarimón J; Yagüe S; Illa I
Clin Neurophysiol; 2011 Dec; 122(12):2537-9. PubMed ID: 21640645
[No Abstract] [Full Text] [Related]
19. Sudden cardiac death in Andersen-Tawil syndrome.
Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
[TBL] [Abstract][Full Text] [Related]
20. Coincidence of Andersen-Tawil syndrome and Marfan syndrome: A case report.
Krych M; Ponińska J; Bilińska ZT; Płoski R; Biernacka EK
Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12624. PubMed ID: 30672637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
